Reaction
Faeces Pale reporting signals
As of the last recalculation, Faeces Pale appears in 2,186 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 41.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lanreotide Acetate | 34 | 41.9 | 42.1 |
| Orlistat | 84 | 32.1 | 32.2 |
| Terbinafine Hydrochloride | 27 | 29.3 | 29.4 |
| Octreotide Acetate | 70 | 22.4 | 22.5 |
| Dolutegravir Sodium | 20 | 21.3 | 21.3 |
| Nirmatrelvir And Ritonavir | 67 | 12.1 | 12.1 |
| Lopinavir And Ritonavir | 17 | 12.0 | 12.0 |
| Amoxicillin And Clavulanate Potassium | 26 | 9.2 | 9.2 |
| Pazopanib Hydrochloride | 25 | 8.9 | 8.9 |
| Piperacillin And Tazobactam | 11 | 8.2 | 8.2 |
| Pancrelipase | 29 | 7.2 | 7.2 |
| Bicalutamide | 11 | 6.9 | 6.9 |
| Ursodiol | 15 | 6.6 | 6.6 |
| Meropenem | 22 | 6.6 | 6.6 |
| Ursosiol | 13 | 6.4 | 6.4 |
| Ribavirin | 40 | 6.0 | 6.0 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 28 | 5.9 | 5.9 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 7 | 5.4 | 5.4 |
| Peginterferon Alfa-2A | 29 | 5.2 | 5.2 |
| Lenvatinib | 17 | 5.0 | 5.0 |
| Lapatinib | 8 | 4.9 | 4.9 |
| Glecaprevir And Pibrentasvir | 5 | 4.3 | 4.3 |
| Nintedanib | 14 | 4.3 | 4.3 |
| Cabozantinib | 21 | 4.2 | 4.2 |
| Tolvaptan | 6 | 3.9 | 3.9 |
| Asfotase Alfa | 4 | 3.8 | 3.8 |
| Trifluridine And Tipiracil | 4 | 3.6 | 3.6 |
| Teriflunomide | 16 | 3.4 | 3.4 |
| Dornase Alfa | 6 | 2.9 | 2.9 |
| Pirfenidone | 11 | 2.6 | 2.6 |
| Rimegepant Sulfate | 3 | 2.3 | 2.3 |
| Dimethyl Fumarate | 25 | 1.9 | 1.9 |
| Abaloparatide | 6 | 1.9 | 1.9 |
| Adapalene | 3 | 0.2 | 0.2 |